- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
DexCom Inc (DXCM)
DexCom Inc stock price live, this page displays NASDAQ DXCM stock exchange data. View the DXCM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the DexCom Inc real time stock price chart below.
What Is the DexCom Inc Stock Price Today?
The DexCom Inc stock price today is 65.12.
What Is the Stock Symbol for DexCom Inc?
The stock ticker symbol for DexCom Inc is DXCM.
Is DXCM the Same as $DXCM?
$DXCM is a common way to refer to the DexCom Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does DexCom Inc Trade On?
DexCom Inc is listed and trades on the NASDAQ stock exchange.
Is DexCom Inc a Good Stock to Buy?
Determining whether DexCom Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current DexCom Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DXCM quote. (ISIN: US2521311074)
What Is the DexCom Inc Stock Price Today?
The DexCom Inc stock price today is 65.12.
What Is the Stock Symbol for DexCom Inc?
The stock ticker symbol for DexCom Inc is DXCM.
Is DXCM the Same as $DXCM?
$DXCM is a common way to refer to the DexCom Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does DexCom Inc Trade On?
DexCom Inc is listed and trades on the NASDAQ stock exchange.
Is DexCom Inc a Good Stock to Buy?
Determining whether DexCom Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current DexCom Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DXCM quote. (ISIN: US2521311074)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
61.54
65.17
52 wk Range
54.11
89.98
DXCM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
61.5465.17
52 wk Range
54.1189.98
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DXCM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
82.44
Upside
+26.60%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Management has been aggressively buying back shares
- DexCom receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- DexCom receives Investment Bank Analyst Rating Update
- Investing.com
Pro - DexCom receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 144 DEXCOM For: 15 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
25 Buy
2 Hold
1 Sell
Ratings:
28 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 82.44
(+26.60% Upside)
DexCom Inc SWOT Analysis
Analyst Outlook | Price targets range from $80 to $102, averaging $91.25, reflecting mixed sentiment as DexCom balances market leadership against competitive threats from Abbott and potential regulatory hurdles. |
Financial Headwinds | Despite robust sales of $1.04 billion in Q1 2025, DexCom faces margin challenges from quality initiatives and supply issues, prompting revised forecasts for 2026. |
Growth Catalysts | Expansion into the Type 2 diabetes market and the upcoming G7 15-day sensor launch present significant opportunities, with 6 million new covered lives expected by year-end 2025. |
Diabetes Tech Leade | DexCom dominates the continuous glucose monitoring market with strong sales growth and record new patient starts, despite facing recent margin pressures from supply chain challenges. |
DexCom Inc Earnings Call Summary for Q1/2026
- DexCom Q1 2026 EPS of $0.56 beat estimates by 19%; revenue of $1.19B exceeded forecasts by 1.71%, driving 3.41% stock gain to $57.99.
- Revenue rose 15% YoY with international sales surging 26% to $360M; U.S. sales increased 11% to $832M on strong CGM system demand.
- Gross margin expanded to 63.5% from 57.5% YoY; operating income jumped to 22.2% of revenue vs. 13.8% in Q1 2025.
- Company raised FY2026 operating margin guidance to 23%-23.5% and EBITDA margin to 31%-31.5%; expects revenue of $5.16B-$5.25B.
- CEO cited sustainable growth and margin expansion; risks include geopolitical cost pressures, competition, and potential supply chain disruptions.
Last Updated: 04/30/2026, 05:54 PM
Read Full TranscriptDexCom investor slides for Q1/2026
Last Update: Apr 30, 2026
See full investor slides
Earnings
Latest Release
Apr 30, 2026
EPS / Forecast
0.56 / 0.47
Revenue / Forecast
1.19B / 1.17B
Compare DXCM to Peers and Sector
Metrics to compare | DXCM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDXCMPeersSector | |
|---|---|---|---|---|
P/E Ratio | 26.3x | 13.5x | −0.5x | |
PEG Ratio | 0.33 | −0.19 | 0.00 | |
Price / Book | 8.3x | 3.1x | 2.6x | |
Price / LTM Sales | 5.1x | 2.6x | 3.2x | |
Upside (Analyst Target) | 32.5% | 70.1% | 52.2% | |
Fair Value Upside | Unlock | 11.3% | 10.4% | Unlock |
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the DexCom (DXCM) Stock Price Today?
The DexCom stock price today is 65.12 USD.
What Stock Exchange Does DexCom Trade On?
DexCom is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for DexCom?
The stock symbol for DexCom is "DXCM."
What Is the DexCom Market Cap?
As of today, DexCom market cap is 25.10B USD.
What Is DexCom's Earnings Per Share (TTM)?
The DexCom EPS (TTM) is 2.34.
When Is the Next DexCom Earnings Date?
DexCom will release its next earnings report on Jul 23, 2026.
From a Technical Analysis Perspective, Is DXCM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has DexCom Stock Split?
DexCom has split 1 times.
How Many Employees Does DexCom Have?
DexCom has 11050 employees.
What is the current trading status of DexCom (DXCM)?
As of May 18, 2026, DexCom (DXCM) is trading at a price of 65.12 USD, with a previous close of 61.63 USD. The stock has fluctuated within a day range of 61.54 USD to 65.17 USD, while its 52-week range spans from 54.11 USD to 89.98 USD.
What Is DexCom (DXCM) Price Target According to Analysts?
The average 12-month price target for DexCom is 82.44 USD, with a high estimate of 112 USD and a low estimate of 64 USD. 25 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Strong Buy. The stock has an +26.60% Upside potential.
What Is the DXCM Premarket Price?
DXCM's last pre-market stock price is 61.75 USD. The pre-market share volume is 459,890.00, and the stock has decreased by 0.12, or 0.19%.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.